<!DOCTYPE html>
<html>
    <head>
        <title>ONALABS QMS : OV E5.6. Risk Management Report</title>
        <link rel="stylesheet" href="styles/site.css" type="text/css" />
        <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    </head>

    <body class="theme-default aui-theme-default">
        <div id="page">
            <div id="main" class="aui-page-panel">
                <div id="main-header">
                    <div id="breadcrumb-section">
                        <ol id="breadcrumbs">
                            <li class="first">
                                <span><a href="index.html">ONALABS QMS</a></span>
                            </li>
                                                    <li>
                                <span><a href="OV-ONAVITAL-MDR-Product-Technical-File_3342337.html">OV ONAVITAL MDR Product Technical File</a></span>
                            </li>
                                                    <li>
                                <span><a href="3342756.html">OV Part E: Risk Management Files</a></span>
                            </li>
                                                </ol>
                    </div>
                    <h1 id="title-heading" class="pagetitle">
                                                <span id="title-text">
                            ONALABS QMS : OV E5.6. Risk Management Report
                        </span>
                    </h1>
                </div>

                <div id="content" class="view">
                    <div class="page-metadata">
                            
        
    
        
    
        
        
            Created by <span class='author'> Richard Bunney</span>, last modified by <span class='editor'> Jaime Punter</span> on May 20, 2025
                        </div>
                    <div id="main-content" class="wiki-content group">
                    <p><span class="status-macro aui-lozenge aui-lozenge-visual-refresh aui-lozenge-error">COMPANY CONFIDENTIAL</span> <span class="status-macro aui-lozenge aui-lozenge-visual-refresh aui-lozenge-error">UNCONTROLLED IF PRINTED</span></p><p>Owner: Jaime Punter, CTO and Quality Representative</p><p> </p><div class="ap-container" id="ap-com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6845299935457983891">

  <div class="ap-content " id="embedded-com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6845299935457983891"></div>
  <script nonce="528a568c4bd9f0fff5a3a25050ba0fb5" class="ap-iframe-body-script">
  (function(){
    var data = {
    "addon_key":"com.automation-consultants.accloud.approvalmacro",
    "uniqueKey":"com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6845299935457983891",
    "key":"ApprovalsStatusMacro",
     "moduleType":"dynamicContentMacros",      "moduleLocation":"content",         "cp":"/wiki",
            "general":"",
    "w":"",
    "h":"",
    "url":"https://ac-cloud.com/approvalmacro/macro/page-status/display?xdm_e=https%3A%2F%2Fonalabs.atlassian.net&xdm_c=channel-com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6845299935457983891&cp=%2Fwiki&xdm_deprecated_addon_key_do_not_use=com.automation-consultants.accloud.approvalmacro&lic=active&cv=1000.0.0-c58bc7260813&traceId=6741ae212c4b4a125eb16898def73239&spanId=2698ee8d557c1fd6&traceSampled=0&jwt=eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiI2MDU0OTY2Yjk0ZDdiOTAwNjkwMmRkMWUiLCJxc2giOiJiZjA1Njc0ZWRiNzM0ODg3MGQ0YThhNTljOWIzZGQ0Nzk1NWMyMWY4ZTZmOTkwNGY0OTM5Njc3MWU1MTBlMGJiIiwiaXNzIjoiNzdjODA3YTAtMmNjNy0zZWVjLWEzNDItOWQzYzYyZjUwZWE0IiwiY29udGV4dCI6e30sImV4cCI6MTc1MTI5NTU4MSwiaWF0IjoxNzUxMjk1NDAxfQ.rj6l0dGe3Rfv6s8BfYHme1xkZp1nDrkQeHdtbSfGXVI",
     "contextJwt": "eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.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.0ak-0lTTw0VBy1cMVLhblhbwrp-WPKMVNQ6U_opywAs",    "structuredContext": "{\"license\":{\"active\":true},\"confluence\":{\"editor\":{\"version\":\"v2\"},\"macro\":{\"outputType\":\"html_export\",\"hash\":\"df673629-6bf5-41ba-9570-27cce8e7c2e8\",\"id\":\"df673629-6bf5-41ba-9570-27cce8e7c2e8\"},\"tracing\":{\"traceId\":\"6741ae212c4b4a125eb16898def73239\",\"spanId\":\"2698ee8d557c1fd6\",\"sampled\":\"0\"},\"content\":{\"type\":\"page\",\"version\":\"7\",\"id\":\"91553793\"},\"space\":{\"key\":\"ONALABSQMS\",\"id\":\"2752512\"}},\"url\":{\"displayUrl\":\"https://onalabs.atlassian.net/wiki\"}}",
    "contentClassifier":"content",
    "productCtx":"{\"page.id\":\"91553793\",\"macro.hash\":\"df673629-6bf5-41ba-9570-27cce8e7c2e8\",\"space.key\":\"ONALABSQMS\",\"tracing.sampled\":\"0\",\"page.type\":\"page\",\"content.version\":\"7\",\"page.title\":\"OV E5.6. Risk Management Report\",\"macro.localId\":\"aa084672-4820-4b24-a3b4-a065e700e605\",\"macro.body\":\"\",\": = | RAW | = :\":null,\"space.id\":\"2752512\",\"macro.truncated\":\"false\",\"content.type\":\"page\",\"output.type\":\"html_export\",\"page.version\":\"7\",\"macro.fragmentLocalId\":\"\",\"content.id\":\"91553793\",\"tracing.traceId\":\"6741ae212c4b4a125eb16898def73239\",\"macro.id\":\"df673629-6bf5-41ba-9570-27cce8e7c2e8\",\"tracing.spanId\":\"2698ee8d557c1fd6\",\"user.isExternalCollaborator\":\"false\",\"editor.version\":\"v2\"}",
    "timeZone":"GB",
    "origin":"https://ac-cloud.com",
    "hostOrigin":"https://onalabs.atlassian.net",
    "sandbox":"allow-downloads allow-forms allow-modals allow-popups allow-popups-to-escape-sandbox allow-scripts allow-same-origin allow-top-navigation-by-user-activation allow-storage-access-by-user-activation",    "pearApp":"true",        "apiMigrations": {
        "gdpr": true
    }
}
;
    if(window.AP && window.AP.subCreate) {
      window._AP.appendConnectAddon(data);
    } else {
      require(['ac/create'], function(create){
        create.appendConnectAddon(data);
      });
    }

    // For Confluence App Analytics. This code works in conjunction with CFE's ConnectSupport.js.
    // Here, we add a listener to the initial HTML page that stores events if the ConnectSupport component
    // has not mounted yet. In CFE, we process the missed event data and disable this initial listener.
    const __MAX_EVENT_ARRAY_SIZE__ = 20;
    const connectAppAnalytics = "ecosystem.confluence.connect.analytics";
    window.connectHost && window.connectHost.onIframeEstablished((eventData) => {
      if (!window.__CONFLUENCE_CONNECT_SUPPORT_LOADED__) {
        let events = JSON.parse(window.localStorage.getItem(connectAppAnalytics)) || [];
        if (events.length >= __MAX_EVENT_ARRAY_SIZE__) {
          events.shift();
        }
        events.push(eventData);
        window.localStorage.setItem(connectAppAnalytics, JSON.stringify(events));
      }
    });

  }());
</script>

</div>
<style type='text/css'>/*<![CDATA[*/
div.rbtoc1751295401491 {padding: 0px;}
div.rbtoc1751295401491 ul {list-style: disc;margin-left: 0px;}
div.rbtoc1751295401491 li {margin-left: 0px;padding-left: 0px;}

/*]]>*/</style><div class='toc-macro rbtoc1751295401491'>
<ul class='toc-indentation'>
<li><a href='#OVE5.6.RiskManagementReport-1.Purpose'>1. Purpose</a></li>
<li><a href='#OVE5.6.RiskManagementReport-2.Scope'>2. Scope</a></li>
<li><a href='#OVE5.6.RiskManagementReport-3.HazardIdentification'>3. Hazard Identification</a></li>
<li><a href='#OVE5.6.RiskManagementReport-4.RiskAnalysisandEvaluation'>4. Risk Analysis and Evaluation</a></li>
<li><a href='#OVE5.6.RiskManagementReport-5.RiskEvaluationMethodologyandCriteria'>5. Risk Evaluation Methodology and Criteria</a></li>
<li><a href='#OVE5.6.RiskManagementReport-6.RiskReduction'>6. Risk Reduction</a></li>
<li><a href='#OVE5.6.RiskManagementReport-7.RiskReductionAssessment'>7. Risk Reduction Assessment</a></li>
<li><a href='#OVE5.6.RiskManagementReport-8.OverallRiskEvaluation'>8. Overall Risk Evaluation</a></li>
<li><a href='#OVE5.6.RiskManagementReport-9.Conclusion–RiskvBenefitEvaluation'>9. Conclusion – Risk v Benefit Evaluation</a></li>
<li><a href='#OVE5.6.RiskManagementReport-10.DocumentDistribution'>10. Document Distribution</a></li>
</ul>
</div><h3 id="OVE5.6.RiskManagementReport-1.Purpose">1. Purpose </h3><p>This report documents the results of risk management undertaken by Onalabs in respect of the OnaVital + device, in accordance with the company’s documented risk management procedure and in accordance with European harmonized standard ISO 14971: 2019, <em>Medical Devices – Application of Risk Management to Medical Devices</em>.  </p><h3 id="OVE5.6.RiskManagementReport-2.Scope">2. Scope</h3><p>The Risk Assessment is constructed in alignment with and applies the good practice principles of ISO14971:2019.</p><h3 id="OVE5.6.RiskManagementReport-3.HazardIdentification">3. Hazard Identification</h3><p>Potential hazards relating to the design, manufacture and intended use of the OnaVital + device were identified through consideration of qualitative and quantitative characteristics relevant to the devices, in accordance with Annex C of ISO 14971: 2019 refer to IHA.</p><h3 id="OVE5.6.RiskManagementReport-4.RiskAnalysisandEvaluation">4. Risk Analysis and Evaluation</h3><p>Analysis of the risks associated with the identified hazards was conducted using a Failure Mode Effects Analysis involving identification of hazard cause, effect and control measures to reduce the risk.  Quantitative values were assigned for severity of harm (of the effect of the hazard) and for probability of occurrence (of the hazard) and used to devise quantitative estimates of risk for each hazard, both before and after the application of specified control measures.</p><p>The results of the risk analysis are presented in the form of an worksheet - refer to FMEA.</p><h3 id="OVE5.6.RiskManagementReport-5.RiskEvaluationMethodologyandCriteria">5. Risk Evaluation Methodology and Criteria </h3><p> </p><p>The quantitative estimates of risk obtained from the risk analysis (both initial and residual risk) were evaluated for acceptance against the criteria documented in Risk Management Plan. </p><p>Based on these criteria, risks were graded either as acceptable or as unacceptable. Risks graded as unacceptable required the introduction of control measures to reduce them to acceptable, practical or risk / benefit analysis if reduction is not possible (also known as – ‘As Far As Possible’ – AFAP). </p><p>For any hazards requiring re-evaluation of residual risk following the introduction of control measures (for the purpose of reducing the initial risk estimate), the evaluation of residual risk was performed using the same criteria as for the initial risk evaluation. </p><h3 id="OVE5.6.RiskManagementReport-6.RiskReduction">6. Risk Reduction</h3><p>Control measures identified to reduce initial risks were identified in the FMEA.</p><p>Risk reduction methods included definition of design and manufacturing specifications, conduct of design verification and validation activities, process validation activities, technical agreements, reference to standards and reference to known established history of acceptable clinical use.</p><h3 id="OVE5.6.RiskManagementReport-7.RiskReductionAssessment">7. Risk Reduction Assessment</h3><p>After the application of the specified risk reduction measures, <strong>no hazards</strong> with an unacceptable level of risk <strong>remained</strong>.</p><h3 id="OVE5.6.RiskManagementReport-8.OverallRiskEvaluation"> 8. Overall Risk Evaluation</h3><p>The risks posed by the design, manufacture and use of the ONAVITAL device have been evaluated in accordance with ISO 14971: 2019. Appropriate control measures have been identified and introduced, when necessary, which did not introduce any new hazards. </p><p>All of the hazards identified during the use of the ONAVITAL devices were associated with an acceptable level of residual risk.  This is justified since:</p><ul><li><p>The hazards identified were associated with a level of residual risk graded “as far as possible.”  </p></li><li><p>Given that the residual risks were graded as “risk is reduced as far as possible (AFAP)” and / or “acceptable”, it is considered that the overall residual risk presented by the ONAVITAL device is acceptable (i.e. no risks were remaining graded as “unacceptable”).</p></li></ul><h3 id="OVE5.6.RiskManagementReport-9.Conclusion–RiskvBenefitEvaluation"> 9. Conclusion – Risk v Benefit Evaluation</h3><p>The overall evaluation found that the overall benefit to the user outweighed the residual risks associated with the devices and was found acceptable.</p><h3 id="OVE5.6.RiskManagementReport-10.DocumentDistribution">10. Document Distribution</h3><div class="table-wrap"><table data-table-width="760" data-layout="default" data-local-id="d51499c6-f4f8-406e-8c0b-d1c031ce9c97" class="confluenceTable"><colgroup><col style="width: 380.0px;"/><col style="width: 380.0px;"/></colgroup><tbody><tr><td class="confluenceTd"><p> </p></td><td class="confluenceTd"><p>Action/ information</p></td></tr><tr><td class="confluenceTd"><p>This document is intended for an internal and (restricted) external audience.</p><p>The external audience may include the following organisations and regulators:</p><ul><li><p>Approved Bodies: conformity assessment bodies for the Medical Device Regulations.</p></li><li><p>Certification Body responsible for auditing and certifying the Quality Management System (QMS) to ISO 13485 </p></li><li><p>Third party contractors and suppliers involved in the manufacture</p></li></ul><p>All external distribution of this document must be approved prior to circulation.</p></td><td class="confluenceTd"><p>Information</p><p> </p></td></tr></tbody></table></div><p> </p>
                    </div>

                                        <div class="pageSection group">
                        <div class="pageSectionHeader">
                            <h2 id="attachments" class="pageSectionTitle">Attachments:</h2>
                        </div>

                        <div class="greybox" align="left">
                                                            <img src="images/icons/bullet_blue.gif" height="8" width="8" alt=""/>
                                <a href="attachments/91553793/91553801.png">image-20210726-105018.png</a> (image/png)
                                <br/>
                                                    </div>
                    </div>
                    
                                                      
                </div>             </div> 
            <div id="footer" role="contentinfo">
                <section class="footer-body">
                    <p>Document generated by Confluence on Jun 30, 2025 15:56</p>
                    <div id="footer-logo"><a href="http://www.atlassian.com/">Atlassian</a></div>
                </section>
            </div>
        </div>     </body>
</html>
